HLK Biotech Holding Group, Inc.
AMHD
Other OTC0.00
USD
- -
- -
ISIN
US40435L1044
CUSIP
40435L104
Return %
Stock
S&P500
1Y
0.00
26.53
3Y
100.00
76.60
5Y
-99.79
80.11
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Anna Petinova
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Address
- 2612 Granby Street Norfolk VA United States of America 23517
- IPO Date
- Feb 11, 1999
- Website
- amelotholdings.com
- Similar Companies
- Business
- HLK Biotech Holding Group, Inc. (AMHD) is a holding company that, through its subsidiaries, produces and sells biodiesel; acquires real estate properties; and focuses on research and development of high-tech health foods, healthcare supplies, and low-carbon environmental protection solutions. The company operates primarily through China-based subsidiaries in the health and alternative energy sectors, targeting markets in the United States and Asia with an emphasis on renewable fuels and biotech products. Founded in 1998 and headquartered at 2612 Granby Street in Norfolk, Virginia, it changed its name from Amelot Holdings, Inc. to HLK Biotech Holding Group, Inc. in February 2018, marking a strategic shift toward biotech and sustainability initiatives. No major acquisitions, funding rounds, partnerships, or new product launches have been reported in the last 1-2 years, with the company maintaining a low operational profile amid minimal revenue activity.